Innovative access to medicines strategies in lower income countries

Dr Nicola Davies explores the market access steps taken by companies such as Takeda to make medicines available and affordable for high priority patient populations.

Billions of people in low and middle-income countries still have little or no access to several important medicines. Subsequently, pharmaceutical companies are expected to take steps to address this.

As Jayasree Iyer, executive director of the independent non-profit Netherlands-based organization Access to Medicine Foundation, says: “There is an increased demand for pharma companies to do business differently in emerging markets.”1